Skip to main content

Advertisement

Table 3 Treatment-related prognosis predictors of patients with GBS

From: Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review

  Number of patients(%) MRC score at discharge Comparison* (P-value)
Treatment    0.975
 IVIg 40 (36.04%) 32.41±14.330  
 IVIg plus glucocorticoid 57 (51.25%) 33.63±8.557  
Treatment    0.175
 IVIg 40 (36.04%) 32.41±14.330  
 Glucocorticoid 11 (9.91%) 37.55±3.616  
Duration between onset and treatment    0.181
 Less than 7 days 55 (49.55%) 32.22±10.906  
 7 to 14 days 30 (27.03%) 33.43±10.897  
 More than 14 days 23 (20.72%) 35.61±7.316  
  1. *p values<0.05 are considered significant.